Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) FCF Margin (2023 - 2025)

BioScience Health Innovations (BHIC) has disclosed FCF Margin for 3 consecutive years, with 6.4% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 184.0% to 6.4% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 3.03% through Dec 2025, up 177.0% year-over-year, with the annual reading at 3.03% for FY2025, 177.0% up from the prior year.
  • FCF Margin for Q4 2025 was 6.4% at BioScience Health Innovations, up from 30.09% in the prior quarter.
  • The five-year high for FCF Margin was 26.76% in Q1 2025, with the low at 206.18% in Q1 2023.
  • Average FCF Margin over 3 years is 34.83%, with a median of 12.77% recorded in 2024.
  • The sharpest move saw FCF Margin skyrocketed 18888bps in 2024, then crashed -3921bps in 2025.
  • Over 3 years, FCF Margin stood at 18.59% in 2023, then skyrocketed by 56bps to 8.24% in 2024, then grew by 22bps to 6.4% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 6.4%, 30.09%, and 16.22% for Q4 2025, Q3 2025, and Q2 2025 respectively.